Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
Life and sciences R&D company Biomind Labs Inc.
Leafly Expands Its Suite Of Advertising Products
Leafly (NASDAQ: LFLY), an online cannabis information resource and marketplace, unveiled three new additions to its suite of advertising products, Leafly Ads.
Trump Ally Kellyanne Conway’s ‘Alternative Facts’ Are Back: She Blasts PA’s Fetterman For Cannabis Overdose Deaths?
In a Monday appearance on Fox News, an appropriate venue for Trump ally Kellyanne Conway, she attacked Pennsylvania Democratic Senate nominee John Fetterman for his outspoken su
The Parent Company Completes The Acquisition Of Calma Cannabis Dispensary
TPCO Holding Corp., (OTCQX: GRAMF) (NEO:GRAM.U) has acquired the remaining 15% equity of its Calma Weho LLC dispensary following receipt of all necessary regulatory approvals.
Canopy’s BioSteel Taps Another Professional Athlete – Soccer Star Alphonso Davies
BioSteel Sports Nutrition Inc., which is majority owned by Canopy Growth Corporation (NASDAQ: CGC) signed international soccer star Alphonso Davies to its growing team of athlete partners.
EXCLUSIVE: Global Psychedelics Company Silo Wellness Acquires Dyscovry Science, Including Access To Its Gov Collaborations
According to information procured exclusively by Benzinga ahead of an official announcement, global psychedelics company Silo Wellness Inc.
Brittney Griner’s Former College Coach Refuses To Comment On Her Russia Detention, Twitter Blows Up
Louisiana State University (LSU) women’s basketball coach Kim Mulkey was asked to comment on Brittney Griner's detention in Russia, to which she abruptly declined.
British American Tobacco Invests $37M In German Cannabis Company, Joining Snoop Dogg
British American Tobacco (BAT) (NYSE: BTI) is investing in German cannabis company Sanity Group GmbH along with Snoop Dogg’s
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: How Are They Commercialized?
(Part four of a four-part series)
Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder?
Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. (OTCQB: TRYPF) filed two provisional patent applications - one for psilocybin therapy for fibromyalgia and another expanding psilocybin-based TRP-8803 development’s IP.